Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/25/2024 | $8.00 | Buy | B. Riley Securities |
12/20/2022 | $8.00 | Buy | Lake Street |
4/11/2022 | $8.00 | Buy | Lake Street |
7/7/2021 | $10.00 | Buy | Craig Hallum |
4 - Performant Healthcare Inc (0001550695) (Issuer)
4 - Performant Financial Corp (0001550695) (Issuer)
4 - Performant Financial Corp (0001550695) (Issuer)
SC 13G/A - Performant Financial Corp (0001550695) (Subject)
SC 13G/A - Performant Financial Corp (0001550695) (Subject)
SC 13G - Performant Financial Corp (0001550695) (Subject)
B. Riley Securities initiated coverage of Performant Financial with a rating of Buy and set a new price target of $8.00
Lake Street resumed coverage of Performant Financial with a rating of Buy and set a new price target of $8.00
Lake Street initiated coverage of Performant Financial with a rating of Buy and set a new price target of $8.00
Performant Financial Corporation (NASDAQ:PFMT) (Performant), primarily operating as Performant Healthcare Solutions, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, is proud to announce the appointment of Dr. Shantanu Agrawal, M.D. to its Board of Directors. Dr. Agrawal brings a wealth of expertise and experience in healthcare policy and payment integrity. As Chief Health Officer at Elevance Health (NYSE:ELV), Dr. Agrawal oversees the whole health strategy, including medical policy and clinical quality, as well as the community health strategy and Elevance Health Foundation. Prior to Elevance Health, Dr. Agrawal held numerous execut
Performant Financial Corporation (NASDAQ:PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for its third quarter ended September 30, 2024: Third Quarter Financial Highlights Healthcare revenues of $30.3 million, compared to $28.5 million in the prior year period, an increase of approximately 6%. Total revenues of $31.5 million, compared to total revenues of $30.0 million in the prior year period. Net loss of $2.4 million, or $(0.03) per diluted share, compared to net loss of $0.6 million, or $(0.01) per diluted share, in the prior year period. Adjusted EBITDA of $1.9 million, compared to $1.8 million in the prior year
Performant Financial Corporation (NASDAQ:PFMT) (the Company), primarily operating under subsidiary Performant Healthcare Solutions, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that the company will report its third quarter 2024 results after the market closes Wednesday November 6, 2024. The Company will also hold a conference call to discuss results at 5:00 pm (Eastern Time) that day. To join the conference call: Dial in 800-717-1738 or 646-307-1865, or Live webcast through company's website here Replay can be found approximately three hours after the call on the company website under the Events & Presentations
Performant Financial Corporation (NASDAQ:PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for its second quarter ended June 30, 2024: Second Quarter Financial Highlights Healthcare revenues of $27.9 million, compared to $23.9 million in the prior year period, an increase of approximately 17%. Total revenues of $29.4 million, compared to total revenues of $25.5 million in the prior year period. Net loss of $3.0 million, or $(0.04) per diluted share, compared to net loss of $4.0 million, or $(0.05) per diluted share, in the prior year period. Adjusted EBITDA of $0.5 million, compared to $(1.3) million in the prior
8-K - Performant Healthcare Inc (0001550695) (Filer)
10-Q - Performant Financial Corp (0001550695) (Filer)
8-K - Performant Financial Corp (0001550695) (Filer)
Performant Healthcare, Inc. (NASDAQ:PFMT) ("Performant" or the "Company") is pleased to announce that its ticker symbol on the Nasdaq stock exchange will change from "PFMT" to "PHLT" effective as of market open on Wednesday, December 18, 2024. The change reflects Performant's strategic evolution into a pure-play healthcare payment integrity leader, underscoring its commitment to providing innovative solutions that reduce waste and abuse in the healthcare system. The transition to "PHLT" requires no action from shareholders. Performant's common shares will continue to be listed on Nasdaq with no changes to the CUSIP number, GICS, and NAICS codes associated with the Company's common stock
New Nasdaq Ticker Symbol Will Be PHLT Performant Financial Corporation (NASDAQ:PFMT) today announced it has changed its name to Performant Healthcare, Inc. ("Performant" or the "Company"), and plans to update its ticker symbol to PHLT. The name change and new ticker symbol will not impact the Company's operations, management or structure. Performant, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, is changing its name to reflect its strategic commitment to becoming a pure-play leader in healthcare payment integrity. "The name Performant Healthcare, Inc. reflects our commitment to delivering world-class payment integrity solution
Performant Financial Corporation (NASDAQ:PFMT) (the "Company"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference, taking place in Boca Raton on Tuesday, December 3rd. Simeon Kohl, CEO, will present and meet with investors to discuss key updates, including the recent New York State Medicaid RAC award, progress on efficiency initiatives aimed at margin improvement, successful commercial implementations and a robust pipeline, and upcoming government opportunities. We're excited to share these developments as we continue dr